Announcements
Eurosurveillance remains in the updated list of the Directory of Open Access Journals (DOAJ). It was first added to the DOAJ on 9 September 2004. Eurosurveillance is also listed in the Securing a Hybrid Environment for Research Preservation and Access / Rights MEtadata for Open archiving (SHERPA/RoMEO) [2], a database which uses a colour‐coding scheme to classify publishers according to their self‐archiving policy and to show the copyright and open access self-archiving policies of academic journals. Eurosurveillance is listed there as a ‘green’ journal, which means that authors can archive pre-print (i.e. pre-refereeing), post-print (i.e. final draft post-refereeing) and archive the publisher's version/PDF.

ESCAIDE participants are invited to the fifth Eurosurveillance scientific seminar on 30 November 2016

Follow Eurosurveillance on Twitter: @Eurosurveillanc

Read our articles on Zika virus infection

Read our articles on mcr-1-mediated colistin resistance

Epidemiological investigation of MERS-CoV spread in a single hospital in South Korea, May to June 2015. Available from: http://www.eurosurveillance.org / ViewArticle.aspx?ArticleId=21169


In this issue


Home Eurosurveillance Edition  2008: Volume 13/ Issue 6 Article 6
Back to Table of Contents
Previous Download (pdf)
Next

Eurosurveillance, Volume 13, Issue 6, 07 February 2008
News
Swiss study suggests condom use not necessary for some HIV-positive patients
  1. Eurosurveillance editorial office

Citation style for this article: Eurosurveillance editorial team. Swiss study suggests condom use not necessary for some HIV-positive patients. Euro Surveill. 2008;13(6):pii=8035. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=8035

 

The United Nations Joint Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) issued a joint statement on 1 February regarding the use of condoms as a measure of protection against the AIDS virus [1]. The statement followed an article by Switzerland’s Federal AIDS Commission, which reviewed a large body of literature to conclude that certain HIV-positive people may be able to have sexual intercourse with their seronegative partners without risk of transmitting the virus. The authors of the Swiss article specified three prerequisites for this conclusion: that the HIV-positive individuals have had undetectable viral load in the blood for at least six months; have adhered strictly to their anti-retroviral treatment; and are free of other sexually transmitted infections. The authors stressed that their conclusion was targeted only at those fulfilling these criteria, and that the decision on whether or not to have sexual intercourse without the protection of a condom should always be that of the seronegative partner.

The UNAIDS/WHO statement reiterated that the two organisations had not changed their guidance that HIV prevention should take a comprehensive approach, including the correct and consistent use of condoms. The statement also underlined that although research cited in the article has shown that an undetectable viral load in blood significantly reduces the risk of transmitting HIV, it has yet to be proven that it completely eliminates that risk.


References

  1. United Nations Joint Programme on HIV/AIDS and World Health Organization. ‘Antiretroviral therapy and sexual transmission of HIV’. Statement. 2008 Feb 1. Available from: http://data.unaids.org/pub/PressStatement/2008/080201_hivtransmission_en.pdf
  2. Vernazza P, Hirschel B, Bernasconi E, Flepp M. Les personnes séropositives ne souffrant d’aucune autre MST et suivant un traitement antirétroviral efficace ne transmettent pas le VIH par voie sexuelle [In French]. Bull Med Suisses. 2008(05):165-169. Available from: http://www.saez.ch

 



Back to Table of Contents
Previous Download (pdf)
Next

The publisher’s policy on data collection and use of cookies.

Disclaimer: The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the editorial team or the institutions with which the authors are affiliated. Neither ECDC nor any person acting on behalf of ECDC is responsible for the use that might be made of the information in this journal. The information provided on the Eurosurveillance site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. Our website does not host any form of commercial advertisement. Except where otherwise stated, all manuscripts published after 1 January 2016 will be published under the Creative Commons Attribution (CC BY) licence. You are free to share and adapt the material, but you must give appropriate credit, provide a link to the licence, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

Eurosurveillance [ISSN 1560-7917] - ©2007-2016. All rights reserved.
 

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.